As seniors become frustrated and Part D enrollment lags, drug benefit plans cannot grow fast enough to manage risk. Some leave the market, and others cut benefits.
Jason Pesile
Advertisement
Articles by Jason Pesile
Advertisement
Latest Updated Articles
Medicare Part D: D for Doomed?Published: May 1st 2006 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Technological Renaissance: AI’s Integration into the Pharmaceutical Industry
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA's History with Complex Plants
4
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
5